telehealth services new jersey compounded glp-1 receptor agonist weight loss TrimRX We are excited to announce
Description
PMID: 38302593
If you or someone you know has suffered from drug-induced gastroparesis or related conditions due to GLP-1 medications, contact Van Wey & Metzler today
Successful implementation of a multidisciplinary weight loss program including GLP1 receptor agonists for liver transplant candidates with high body mass index
These therapies are widely used in hospitals, specialty clinics, and outpatient settings, with growing applications in chronic weight management and cardiovascular risk reduction
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
